PureTech Health plc (PRTC)

R&D Expense Growth

-15.73%

Fiscal year · Period ending:

PRTC logo

PRTC R&D Expense Growth

Latest reported-15.73%
PRTC FY R&D Growth (YoY) (0.00% → -15.73%)
High-resolution chart · PNG

PRTC r&d expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

PureTech Health plc R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense Growth
-15.7277%
-43.5964%
-17.1195%
42.4332%
33.2347%
-6.1075%
13.7416%
-20.0622%
73.9401%
207.3165%
372.7786%
0.1412%
-33.018%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.